• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.

作者信息

Regårdh C G, Borg K O, Johansson R, Johnsson G, Palmer L

出版信息

J Pharmacokinet Biopharm. 1974 Aug;2(4):347-64. doi: 10.1007/BF01061407.

DOI:10.1007/BF01061407
PMID:4155762
Abstract
摘要

相似文献

1
Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.人用选择性β1受体拮抗剂美托洛尔的药代动力学研究。
J Pharmacokinet Biopharm. 1974 Aug;2(4):347-64. doi: 10.1007/BF01061407.
2
Proceedings: Relationship between the pharmacokinetic and pharmacodynamic properties of the beta-receptor antagonists alprenolol and metoprolol.会议论文：β受体拮抗剂阿普洛尔和美托洛尔的药代动力学与药效学特性之间的关系
Acta Pharm Suec. 1974 Dec;11(6):660.
3
Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.某些肾上腺素能β受体拮抗剂的药代动力学和生物药剂学，特别着重于阿普洛尔和美托洛尔。
Acta Pharmacol Toxicol (Copenh). 1975;37(1):1-39. doi: 10.1111/j.1600-0773.1975.tb03091.x.
4
[Clinical pharmacology of trimepranol (pharmacokinetic informations and effects on heart rate in healthy individuals)].[曲美托嗪的临床药理学（健康个体的药代动力学信息及对心率的影响）]
Vnitr Lek. 1976 Nov;22(11):1102-9.
5
Esmolol: a pharmacokinetic profile of a new cardioselective beta-blocking agent.艾司洛尔：一种新型心脏选择性β受体阻滞剂的药代动力学概况。
J Pharm Sci. 1983 Jun;72(6):710-1. doi: 10.1002/jps.2600720632.
6
Pharmacokinetic studies of metoprolol-(3-h) in the rat and the dog.美托洛尔 -（3 - h）在大鼠和犬体内的药代动力学研究。
Acta Pharmacol Toxicol (Copenh). 1975;36(Suppl 5):104-15. doi: 10.1111/j.1600-0773.1975.tb03327.x.
7
Combined pharmacokinetic and pharmacodynammc studies in man of the adrenergic beta1-receptor antagonist metoprolol.肾上腺素能β1受体拮抗剂美托洛尔在人体中的药代动力学和药效学联合研究。
Acta Pharmacol Toxicol (Copenh). 1975;36(Suppl 5):31-44. doi: 10.1111/j.1600-0773.1975.tb03320.x.
8
Studies on the metabolism of the beta-adrenoceptor antagonists alprenolol, metoprolol and pamatolol.β-肾上腺素能受体拮抗剂阿普洛尔、美托洛尔和帕马洛尔的代谢研究。
Acta Pharm Suec. 1979;16(2):160.
9
Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings].
Br J Clin Pharmacol. 1979 Oct;8(4):408P. doi: 10.1111/j.1365-2125.1979.tb04755.x.
10
Pharmacokinetics of single and multiple doses of flusoxolol (Ro 31-1411) in healthy subjects.
Eur J Clin Pharmacol. 1986;31(1):113-5. doi: 10.1007/BF00870998.

引用本文的文献

1
Effect of β-blockade on measures and reproducibility of heart rate, oxygen uptake and work rate across repeated bouts of short-duration, RPE-regulated exercise.β受体阻滞剂对短时间、自感用力度调节的重复运动中，心率、摄氧量和运动强度测量值及可重复性的影响。
Eur J Appl Physiol. 2025 Jun 1. doi: 10.1007/s00421-025-05818-x.
2
Physiologically Based Pharmacokinetic Model To Predict Metoprolol Disposition in Healthy and Disease Populations.用于预测美托洛尔在健康人群和疾病人群中处置情况的基于生理的药代动力学模型。
ACS Omega. 2023 Aug 3;8(32):29302-29313. doi: 10.1021/acsomega.3c02673. eCollection 2023 Aug 15.
3
The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil.

本文引用的文献

1
Direct proportionality of urinary excretion rate and serum level of tetracycline in human subjects.人体受试者中四环素的尿排泄率与血清水平的直接比例关系。
Nature. 1963 May 4;198:450-3. doi: 10.1038/198450a0.
2
Per cent absorbed time plots derived from blood level and/or urinary excretion data.根据血药浓度和/或尿排泄数据得出的吸收百分比-时间曲线图。
J Pharm Sci. 1963 Jun;52:610-1. doi: 10.1002/jps.2600520629.
3
New method for calculating the intrinsic absorption rate of drugs.计算药物内在吸收速率的新方法。
细胞旁路转运在米诺地尔肠道吸收及生物药剂学特征中的作用
Pharmaceutics. 2022 Jun 27;14(7):1360. doi: 10.3390/pharmaceutics14071360.
4
Clinical Pharmacokinetics of Metoprolol: A Systematic Review.美托洛尔的临床药代动力学：系统评价。
Clin Pharmacokinet. 2022 Aug;61(8):1095-1114. doi: 10.1007/s40262-022-01145-y. Epub 2022 Jun 28.
5
Development of Extended-Release Mini-Tablets Containing Metoprolol Supported by Design of Experiments and Physiologically Based Biopharmaceutics Modeling.基于实验设计和生理药剂学模型的美托洛尔缓释微型片的研发
Pharmaceutics. 2022 Apr 19;14(5):892. doi: 10.3390/pharmaceutics14050892.
6
Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.体外治疗β-肾上腺素能拮抗剂中毒：EXTRIP 工作组的系统评价和建议。
Crit Care. 2021 Jun 10;25(1):201. doi: 10.1186/s13054-021-03585-7.
7
Day-to-day progression of vital-sign circadian rhythms in the intensive care unit.重症监护病房生命体征昼夜节律的日常进展。
Crit Care. 2021 Apr 22;25(1):156. doi: 10.1186/s13054-021-03574-w.
8
Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene Interactions.美托洛尔对映体和α-羟基美托洛尔的基于生理的药代动力学建模以描述CYP2D6药物-基因相互作用
Pharmaceutics. 2020 Dec 11;12(12):1200. doi: 10.3390/pharmaceutics12121200.
9
Prediction of Tissue-Plasma Partition Coefficients Using Microsomal Partitioning: Incorporation into Physiologically based Pharmacokinetic Models and Steady-State Volume of Distribution Predictions.利用微粒体分配预测组织-血浆分配系数：纳入基于生理的药代动力学模型和稳态分布容积预测。
Drug Metab Dispos. 2019 Oct;47(10):1050-1060. doi: 10.1124/dmd.119.087973. Epub 2019 Jul 19.
10
Cytochrome P450 Enzymes Involved in Metoprolol Metabolism and Use of Metoprolol as a CYP2D6 Phenotyping Probe Drug.参与美托洛尔代谢的细胞色素P450酶以及美托洛尔作为CYP2D6表型分析探针药物的应用。
Front Pharmacol. 2018 Jul 24;9:774. doi: 10.3389/fphar.2018.00774. eCollection 2018.
J Pharm Sci. 1968 Jun;57(6):918-28. doi: 10.1002/jps.2600570602.
4
Influence of first-pass effect on availability of drugs on oral administration.首过效应对口服给药时药物可利用度的影响。
J Pharm Sci. 1971 Sep;60(9):1338-40. doi: 10.1002/jps.2600600909.
5
Pharmacokinetic model for chlordiazepoxide--HCl in the dog.狗体内氯氮䓬盐酸盐的药代动力学模型。
J Pharm Sci. 1970 Nov;59(11):1569-74. doi: 10.1002/jps.2600591105.
6
Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.通过静脉输注后获得的输注后血药浓度曲线评估药代动力学常数。
J Pharm Sci. 1970 Jan;59(1):53-5. doi: 10.1002/jps.2600590107.
7
The disposition of propranolol. I. Elimination during oral absorption in man.普萘洛尔的处置。I. 人体口服吸收过程中的消除
Pharmacology. 1972;7(3):159-68. doi: 10.1159/000136285.
8
Influence of route of administration on drug availability.给药途径对药物可利用性的影响。
J Pharm Sci. 1972 Jan;61(1):70-4. doi: 10.1002/jps.2600610111.
9
Prediction of systemic availability from plasma-level data after oral drug administration.
J Pharm Pharmacol. 1973 Mar;25(3):256-7. doi: 10.1111/j.2042-7158.1973.tb10634.x.
10
Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists.两种新型心脏选择性肾上腺素能β受体拮抗剂的药理学研究
Life Sci I. 1973 Feb 1;12(3):107-19. doi: 10.1016/0024-3205(73)90368-8.